Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?

Journal article

Brian K Link

Leukemia & lymphoma, Vol.53(8), pp.1435-1436

08/2012

DOI: 10.3109/10428194.2012.672737

PMID: 22397718

View Online

no abstract | commentary

Doxorubicin - therapeutic use

Geriatrics - methods

Medical Oncology - methods

Lymphoma, Large B-Cell, Diffuse - drug therapy

Antineoplastic Combined Chemotherapy Protocols - therapeutic use

Humans

Vincristine - therapeutic use

Female

Male

Cyclophosphamide - therapeutic use

Prednisone - therapeutic use

Antibodies, Monoclonal, Murine-Derived - therapeutic use

Title: Subtitle: Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?
Creators: Brian K Link - University of Iowa College of Medicine, Iowa City, IA 52242, USA. brian-link@uiowa.edu
Resource Type: Journal article
Publication Details: Leukemia & lymphoma, Vol.53(8), pp.1435-1436
DOI: 10.3109/10428194.2012.672737
PMID: 22397718
ISSN: 1042-8194
eISSN: 1029-2403
Language: English
Date published: 08/2012
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984094367102771

13 Record Views